SciSparc Valuation

Is SPRC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SPRC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SPRC's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SPRC's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SPRC?

Key metric: As SPRC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SPRC. This is calculated by dividing SPRC's market cap by their current revenue.
What is SPRC's PS Ratio?
PS Ratio0.5x
SalesUS$1.75m
Market CapUS$811.18k

Price to Sales Ratio vs Peers

How does SPRC's PS Ratio compare to its peers?

The above table shows the PS ratio for SPRC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.2x
GSAC GelStat
4.9xn/aUS$1.0m
KOAN Resonate Blends
0.8xn/aUS$602.4k
RLBD Real Brands
7xn/aUS$269.1k
EVFM Evofem Biosciences
0.06xn/aUS$1.0m
SPRC SciSparc
0.5xn/aUS$811.2k

Price-To-Sales vs Peers: SPRC is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (3.2x).


Price to Sales Ratio vs Industry

How does SPRC's PS Ratio compare vs other companies in the US Pharmaceuticals Industry?

68 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.2.4x10.1%
SPRC SciSparc
0.5xn/aUS$811.18k
OGN Organon
0.6x-0.06%US$3.89b
PRGO Perrigo
0.8x3.4%US$3.67b
SPRC 0.5xIndustry Avg. 2.4xNo. of Companies68PS03.67.210.814.418+
68 CompaniesEstimated GrowthMarket Cap
Industry Avg.2.4x23.9%
SPRC SciSparc
0.5x63.0%US$811.18k
No more companies

Price-To-Sales vs Industry: SPRC is good value based on its Price-To-Sales Ratio (0.5x) compared to the US Pharmaceuticals industry average (2.4x).


Price to Sales Ratio vs Fair Ratio

What is SPRC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SPRC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.5x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate SPRC's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies